Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$18,081,408
+$4,073,311 QoQ
Shares Held
15,075
-1.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
3.66%
of 13F equity value
Holder Rank
#934
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROWLANDMILLER & PARTNERS.ADV holds $61,867,127 across 7 Drug Manufacturers - General names. LLY ranks #1 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
15,075 | $18,081,408 | |
| 2 | JNJ |
Johnson & Johnson
|
64,152 | $16,292,683 | |
| 3 | ABBV |
AbbVie Inc.
|
43,246 | $10,882,423 | |
| 4 | AMGN |
Amgen Inc
|
14,748 | $5,340,545 | |
| 5 | MRK |
Merck & Co., Inc.
|
37,007 | $4,755,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
36,350 | $4,592,459 | |
| 7 | PFE |
Pfizer Inc
|
79,826 | $1,922,210 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,081,408 | 15,075 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $14,008,097 | 15,230 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $17,650,545 | 16,424 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,273,911 | 17,397 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $14,866,416 | 19,071 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $15,804,613 | 19,136 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $15,301,040 | 19,820 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $18,267,196 | 20,619 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $18,731,406 | 20,689 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $17,432,527 | 22,408 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $13,596,026 | 23,324 | Shares | Sole | 2024-01-03 | |
| 2023-09-30 | $12,923,884 | 24,061 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $11,515,334 | 24,554 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $8,613,660 | 25,082 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $9,727,685 | 26,590 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $9,243,283 | 28,586 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $9,452,601 | 29,154 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,723,116 | 30,461 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $9,121,060 | 33,021 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,840,897 | 38,264 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $8,287,049 | 36,106 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $6,741,960 | 36,088 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $6,236,611 | 36,938 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,830,507 | 39,390 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,282,183 | 38,264 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,464,180 | 39,390 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||